Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New target for developing effective anti-depressants

12.04.2011
For the first time in a human model, scientists have discovered how anti-depressants make new brain cells. This means that researchers can now develop better and more efficient drugs to combat depression.

Previous studies have shown that anti-depressants make new brain cells, however, until now it was not known how they did it. In a study to be published in the journal Molecular Psychiatry, researchers from the Institute of Psychiatry, King's College London, show that anti-depressants regulate the glucocorticoid receptor (GR) - a key protein involved in the stress response. Moreover, the study shows that all types of anti-depressant are dependent on the GR to create new cells.

Depression is expected to be the second leading burden of disease world wide by the year 2020. Recent studies have demonstrated that depressed patients show a reduction in a process called 'neurogenesis', that is, a reduction in the development of new brain cells. This reduced neurogenesis may contribute to the debilitating psychological symptoms of depression, such as low mood or impaired memory. With as much as half of all depressed patients failing to improve with currently available treatments, developing new effective anti-depressant treatment still remains a great challenge, which makes it crucial to identify new potential mechanisms to target.

The Laboratory of Stress, Psychiatry and Immunology (SPI-lab) at King's has been looking into the role of the GR in depression for a number of years. In this study, scientists used human hippocampal stem cells, the source of new cells in the human brain, as a new model to investigate 'in a dish' the effects of anti-depressants on brain cells.

Christoph Anacker, PhD student at the Institute of Psychiatry at King's and lead author of the study said: 'For the first time in a clinically relevant model, we were able to show that anti-depressants produce more stem cells and also accelerate their development into adult brain cells. Additionally, we demonstrate for the first time that stress hormones, which are generally very high in depressed patients, show the opposite effect.

'We discovered that a specific protein in the cell, the glucocorticoid receptor, is essential for this to take place. The anti-depressants activate this protein which switches on particular genes that turn immature 'stem' cells into adult 'brain' cells.

'By increasing the number of new-born cells in the adult human brain, anti-depressants counteract the damaging effects of stress hormones and may overcome the brain abnormalities which may cause low mood and impaired memory in depression.'

Anacker concludes: 'Having identified the glucocorticoid receptor as a key player in making new brain cells, we will now be able to use this novel stem cell system to model psychiatric illnesses in the laboratory, test new compounds and develop much more effective, targeted anti-depressant drugs. However, first it is important that future studies investigate all possible effects that the increase of neurogenesis has on behaviour in humans.'

This study was funded by the National Institute for Health Research Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust & Institute of Psychiatry, King's College London, and the UK Medical Research Council. The study was jointly led by the senior authors Dr Carmine M. Pariante, at the Laboratory of Stress, Psychiatry and Immunology in the Department of Psychological Medicine, and Dr Sandrine Thuret and Professor Jack Price, at the Centre for the Cellular Basis of Behaviour, all based at Institute of Psychiatry King's College London.

Louise Pratt | EurekAlert!
Further information:
http://www.kcl.ac.uk

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>